Conventional Imaging, MRI and <sup>18</sup>F-FDG PET/MRI for N and M Staging in Patients with Newly Diagnosed Breast Cancer

Conventional Imaging, MRI and <sup>18</sup>F-FDG PET/MRI for N and M Staging in Patients with Newly Diagnosed Breast Cancer

<b>Background:</b> This study compares the diagnostic potential of conventional staging (computed tomography (CT), axillary sonography and bone scintigraphy), whole-body magnetic resonance imaging (MRI) and whole-body <sup>18</sup>F-fluorodeoxyglucose positron emission tomogr...

Full description

Bibliographic Details
Main Authors: Janna Morawitz, Nils-Martin Bruckmann, Kai Jannusch, Frederic Dietzel, Aleksandar Milosevic, Ann-Kathrin Bittner, Oliver Hoffmann, Svjetlana Mohrmann, Eugen Ruckhäberle, Lena Häberle, Wolfgang Peter Fendler, Ken Herrmann, Frederik Lars Giesel, Gerald Antoch, Lale Umutlu, Bernd Kowall, Andreas Stang, Julian Kirchner
Format: Article
Language:English
Published: MDPI AG 2023-07-01
Series:Cancers
Subjects:
breast cancer
metastases
staging
<sup>18</sup>F-FDG PET/MRI
Online Access:https://www.mdpi.com/2072-6694/15/14/3646

Internet

https://www.mdpi.com/2072-6694/15/14/3646

Similar Items